Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations.
Rocco N, Catanuto G, Cinquini M, Audretsch W, Benson J, Criscitiello C, Di Micco R, Kovacs T, Kuerer H, Lozza L, Montagna G, Moschetti I, Nafissi N, O'Connell RL, Oliveri S, Pau L, Scaperrotta G, Thoma A, Winters Z, Nava MB. Rocco N, et al. Among authors: criscitiello c. Breast. 2021 Jun;57:25-35. doi: 10.1016/j.breast.2021.02.013. Epub 2021 Feb 26. Breast. 2021. PMID: 33711697 Free PMC article. Review.
Locoregional recurrence in patients with HER2 positive breast cancer.
Brollo J, Kneubil MC, Botteri E, Rotmensz N, Duso BA, Fumagalli L, Locatelli MA, Criscitiello C, Lohsiriwat V, Goldhirsch A, Leonardi MC, Orecchia R, Curigliano G. Brollo J, et al. Among authors: criscitiello c. Breast. 2013 Oct;22(5):856-62. doi: 10.1016/j.breast.2013.03.010. Epub 2013 May 1. Breast. 2013. PMID: 23642529
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in luminal B HER2 negative and node-positive breast cancer.
Criscitiello C, Disalvatore D, De Laurentiis M, Gelao L, Fumagalli L, Locatelli M, Bagnardi V, Rotmensz N, Esposito A, Minchella I, De Placido S, Santangelo M, Viale G, Goldhirsch A, Curigliano G. Criscitiello C, et al. Breast. 2014 Feb;23(1):69-75. doi: 10.1016/j.breast.2013.11.007. Epub 2013 Dec 4. Breast. 2014. PMID: 24314620
Over-using chemotherapy in the adjuvant setting.
Curigliano G, Criscitiello C, Esposito A, Pruneri G. Curigliano G, et al. Among authors: criscitiello c. Breast. 2017 Feb;31:303-308. doi: 10.1016/j.breast.2016.11.011. Epub 2016 Nov 17. Breast. 2017. PMID: 27866835
Peptide vaccines in early breast cancer.
Criscitiello C, Viale G, Curigliano G. Criscitiello C, et al. Breast. 2019 Apr;44:128-134. doi: 10.1016/j.breast.2019.02.003. Epub 2019 Feb 7. Breast. 2019. PMID: 30769238 Review.
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM).
Dieci MV, Del Mastro L, Cinquini M, Montemurro F, Biganzoli L, Cortesi L, Zambelli A, Criscitiello C, Levaggi A, Conte B, Calabrese M, Fiorentino A, Marchiò C, Tinterri C, Fittipaldo VA, Pappagallo G, Gori S. Dieci MV, et al. Among authors: criscitiello c. Cancers (Basel). 2019 Aug 8;11(8):1137. doi: 10.3390/cancers11081137. Cancers (Basel). 2019. PMID: 31398896 Free PMC article.
Expression of tumor-associated antigens in breast cancer subtypes.
Curigliano G, Bagnardi V, Ghioni M, Louahed J, Brichard V, Lehmann FF, Marra A, Trapani D, Criscitiello C, Viale G. Curigliano G, et al. Among authors: criscitiello c. Breast. 2020 Feb;49:202-209. doi: 10.1016/j.breast.2019.12.002. Epub 2019 Dec 12. Breast. 2020. PMID: 31869767 Free PMC article.
184 results